All Pfizer Articles
Pharma’s Evolving 2024 Acquisition Spree – $ABBV $EPRX $GILD $JNJ $LLY $MRK $NVS $VRTX
Based on reports from The Wall Street Journal, major pharmaceutical companies are shifting their focus to smaller acquisitions in 2024, with all 17 deals announced in the first half of the year valued at $5 billion or less, reflecting a changing regulatory landscape and a more selective approach to ...
Aug 21, 2024
View Article
AI Firm Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial Led By Dr. Yashushi Goto At The National Cancer Center of Japan – $LTRN
According to the American Cancer Society, lung cancer is the second leading cause of cancer in the US, with over 200,000 patients diagnosed annually. Historically, never smokers with NSCLC make up about 15-20% of all lung cancer patients, representing an approximate annual market potential of $1.5 t...
Apr 22, 2024
View Article
Stay Informed. Stay Competitive.
Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly and quarterly investing ideas, strategies, and marketing insights.
We value your privacy and will never share your information.
Recent Posts
VP Watchlist
Trending Posts
-
Elon Musk’s xAI’s Record-Breaking Star-Studded Funding – $TSLA...
-
Exploring Disney’s CEO Succession Plan – $DIS $MS...
-
AI Firm Lantern Pharma Gains 3 FDA Rare...
-
Dealing With Eosinophilic Esophagitis (EoE): The Unwanted Guest...
-
Vista Alert: Indaptus Therapeutics Offers Novel Immunotherapy Decoy20...